Abeona Therapeutics Inc. Stock
Price
Target price
€7.40
€7.40
6.120%
0.45
6.120%
€21.05
17.04.24 / Tradegate
WKN: A3DMHM / Symbol: ABEO / Name: Abeona Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Abeona Therapeutics Inc. Stock
A very strong showing by Abeona Therapeutics Inc. today, with an increase of €0.45 (6.120%) compared to yesterday's price.
Our community is currently high on Abeona Therapeutics Inc. with 3 Buy predictions and 1 Sell predictions.
Based on the current price of 7.4 € the target price of 21 € shows a potential of 183.78% for Abeona Therapeutics Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Abeona Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "EBIT Margin" there were negative voices in the community.
Pros and Cons of Abeona Therapeutics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Abeona Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Abeona Therapeutics Inc. | 6.120% | 7.246% | -6.801% | 195.056% | 57.113% | -76.433% | - |
| Ardelyx Inc. | -1.870% | -7.414% | -16.973% | 36.533% | 6.298% | -15.255% | - |
| Salarius Pharmaceuticals Inc. | -0.930% | 6.468% | -31.520% | -69.209% | -22.883% | -98.226% | -99.994% |
| Evolus Inc | -2.630% | -5.882% | -12.500% | 43.590% | 19.786% | 18.519% | - |
Comments
Abeona Therapeutics Inc (NASDAQ: ABEO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $38.00 price target on the stock.
Show more
Ratings data for ABEO provided by MarketBeat
